Equity Research firms currently have a positive stance on shares of WAVE Life Sciences Ltd. (NASDAQ:WVE). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.50. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $32.25 on a short term basis.
At the time of writing, the stock was trading at $30.01. This represents a change from the opening price of 1.63%. In terms of performance, year to date, the stock is 85.83%. The monthly stock performance comes in at 12.96%. For the quarter, shares are performing at 31.91%. Weekly performance analysis shows the equity at -7.86%.
In taking a look at technical levels, shares are trading 20.43% away from the 50 day simple moving average and 66.61% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -19.54% away from it’s 52- week high and 235.31% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, WAVE Life Sciences Ltd.’s RSI stands at 55.67. In looking at volatility levels, the shares saw weekly volatility of 10.50% and 9.18% over the past month.